IGFBP7
Insulin-like growth factor-binding protein 7
Also known as: FSTL2, IBP7_HUMAN, IGFBP-7, MAC25, PSF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16270
- Gene
- IGFBP7
- Ensembl
- ENSG00000163453
- Chromosome
- 4
- Canonical length
- 282 aa
- Protein class
- Disease related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the insulin-like growth factor (IGF)-binding protein (IGFBP) family. IGFBPs bind IGFs with high affinity, and regulate IGF availability in body fluids and tissues and modulate IGF binding to its receptors. This protein binds IGF-I and IGF-II with relatively low affinity, and belongs to a subfamily of low-affinity IGFBPs. It also stimulates prostacyclin production and cell adhesion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, and one variant has been associated with retinal arterial macroaneurysm (PMID:21835307). [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
282 residues, UniProt reviewed canonical sequence.
>Q16270|IGFBP7
1 MERPSLRALL LGAAGLLLLL LPLSSSSSSD TCGPCEPASC PPLPPLGCLL GETRDACGCC
61 PMCARGEGEP CGGGGAGRGY CAPGMECVKS RKRRKGKAGA AAGGPGVSGV CVCKSRYPVC
121 GSDGTTYPSG CQLRAASQRA ESRGEKAITQ VSKGTCEQGP SIVTPPKDIW NVTGAQVYLS
181 CEVIGIPTPV LIWNKVKRGH YGVQRTELLP GDRDNLAIQT RGGPEKHEVT GWVLVSPLSK
241 EDAGEYECHA SNSQGQASAS AKITVVDALH EIPVKKGEGA ELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGFBP7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 4,198 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 4,198 nTPM
- choroid plexus: 1,635 nTPM
- kidney: 1,206 nTPM
- heart muscle: 1,075 nTPM
- thyroid gland: 958 nTPM
- adipose tissue: 791 nTPM
Single-cell type
- peritubular myoid cells: 11,372 nCPM
- leydig cells: 8,234 nCPM
- hepatic stellate cells: 7,539 nCPM
- pericytes: 5,056 nCPM
- vascular smooth muscle cells: 4,157 nCPM
- decidual stromal cells: 3,076 nCPM
Immune cell
- eosinophil: 22 nTPM
- NK-cell: 11 nTPM
- myeloid DC: 11 nTPM
- non-classical monocyte: 4.5 nTPM
- intermediate monocyte: 4.1 nTPM
- classical monocyte: 3.9 nTPM
Brain region
- choroid plexus: 2,655 nTPM
- thalamus: 327 nTPM
- medulla oblongata: 313 nTPM
- hypothalamus: 219 nTPM
- pons: 218 nTPM
- midbrain: 210 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IGFBP7.
Disease | AllUniProt
Conditions IGFBP7 is implicated in, by any mechanism.
- Retinal arterial macroaneurysm with supravalvular pulmonic stenosis (RAMSVPS) MIM:614224
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 55 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial retinal arterial macroaneurysm
- Retinal arterial macroaneurysm with supravascular pulmonic stenosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cell adhesion
- cellular response to prostaglandin E stimulus
- embryo implantation
- negative regulation of cell population proliferation
- regulation of cell growth
- regulation of signal transduction
- regulation of steroid biosynthetic process
- response to cortisol
- response to retinoic acid
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Insulin-like growth factor-binding protein, IGFBP
- Kazal domain
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Growth factor receptor cysteine-rich domain superfamily
- Insulin-like growth factor binding protein-related protein (IGFBP-rP), MAC25
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Kazal domain superfamily
- Immunoglobulin-like domain superfamily
- Insulin-like growth factor binding protein
- Kazal-type serine protease inhibitor domain
- Immunoglobulin I-set domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IGFBP7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGFBP7 as an antibody target. Whether an autoantibody or antibody against IGFBP7 could matter depends on whether native IGFBP7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGFBP7 is annotated as secreted, so native IGFBP7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IGFBP7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...